Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 4
2006 2
2007 1
2008 1
2009 2
2010 4
2011 1
2012 2
2013 1
2014 1
2015 4
2017 1
2018 3
2019 3
2020 4
2021 4
2022 4
2023 6
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
Oliver-Caldés A, González-Calle V, Cabañas V, Español-Rego M, Rodríguez-Otero P, Reguera JL, López-Corral L, Martin-Antonio B, Zabaleta A, Inogés S, Varea S, Rosiñol L, López-Díaz de Cerio A, Tovar N, Jiménez R, López-Parra M, Rodríguez-Lobato LG, Sánchez-Salinas A, Olesti E, Calvo-Orteu M, Delgado J, Pérez-Simón JA, Paiva B, Prósper F, Sáez-Peñataro J, Juan M, Moraleda JM, Mateos MV, Pascal M, Urbano-Ispizua A, Fernández de Larrea C. Oliver-Caldés A, et al. Among authors: lopez parra m. Lancet Oncol. 2023 Aug;24(8):913-924. doi: 10.1016/S1470-2045(23)00222-X. Epub 2023 Jul 3. Lancet Oncol. 2023. PMID: 37414060 Free article.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Oliver-Caldes A, Español-Rego M, Zabaleta A, González-Calle V, Navarro-Velázquez S, Inogés S, de Cerio AL, Cabañas V, López-Muñoz N, Rodríguez-Otero P, Reguera JL, Moreno DF, Martínez-Cibrian N, López-Corral L, Pérez-Amill L, Martin-Antonio B, Rosiñol L, Cid J, Tovar N, Sáez-Peñataro J, López-Parra M, Olesti E, Guillén E, Varea S, Rodríguez-Lobato LG, Battram AM, González MS, Sánchez-Salinas A, González-Navarro A, Ortiz-Maldonado V, Delgado J, Prósper F, Juan M, Martínez-López J, Moraleda JM, Mateos MV, Urbano-Ispizua Á, Paiva B, Pascal M, Fernández de Larrea C. Oliver-Caldes A, et al. Among authors: lopez parra m. Clin Cancer Res. 2024 May 15;30(10):2085-2096. doi: 10.1158/1078-0432.CCR-23-3759. Clin Cancer Res. 2024. PMID: 38466644
A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma.
Puertas B, Fernández-Sánchez A, Alejo E, Rey-Búa B, Martín-López AA, Pérez-López E, López-Parra M, López-Corral L, Gutiérrez-Gutiérrez NC, García-Sanz R, Puig N, González-Calle V, Mateos MV. Puertas B, et al. Among authors: lopez parra m. Blood Adv. 2024 Jul 9;8(13):3478-3487. doi: 10.1182/bloodadvances.2024012773. Blood Adv. 2024. PMID: 38717869 Free PMC article.
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome.
Fernández-Santos ME, Garcia-Arranz M, Andreu EJ, García-Hernández AM, López-Parra M, Villarón E, Sepúlveda P, Fernández-Avilés F, García-Olmo D, Prosper F, Sánchez-Guijo F, Moraleda JM, Zapata AG. Fernández-Santos ME, et al. Among authors: lopez parra m. Front Immunol. 2022 Jun 9;13:918565. doi: 10.3389/fimmu.2022.918565. eCollection 2022. Front Immunol. 2022. PMID: 35812460 Free PMC article. Review.
MRI of the Normal Elbow and Common Pathologic Conditions.
Acosta Batlle J, Cerezal L, Márquez MV, López Parra MD, Soteras C, Resano S, Sánchez JB. Acosta Batlle J, et al. Among authors: lopez parra md. Radiographics. 2020 Mar-Apr;40(2):468-469. doi: 10.1148/rg.2020190134. Radiographics. 2020. PMID: 32125957 Review. No abstract available.
Autonomic dysfunction as manifestation of ICANS: A case report.
Rochate D, González-García AM, Santos Marcos C, Pérez-López E, Martín-López AÁ, Alaña M, Martín Martín L, López Parra M, Sánchez Guijo F, López Corral L. Rochate D, et al. Among authors: lopez parra m. Medicine (Baltimore). 2024 Sep 6;103(36):e38659. doi: 10.1097/MD.0000000000038659. Medicine (Baltimore). 2024. PMID: 39252328
Autologous mesenchymal stromal cells embedded with Tissucol Duo® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up.
Jiménez MF, Gómez-Hernández MT, Villarón EM, López-Parra M, Sánchez-Guijo F. Jiménez MF, et al. Among authors: lopez parra m. Stem Cell Res Ther. 2023 Oct 31;14(1):313. doi: 10.1186/s13287-023-03545-8. Stem Cell Res Ther. 2023. PMID: 37904229 Free PMC article. Clinical Trial.
Lumbar epidural vein thrombosis mimicking disc herniation: A report of 3 cases.
Salgado-Parente A, Arévalo Galeano N, Almeida-Aróstegui N, Quiñones-Tapia D, López Parra MD, Acosta-Batlle J, Blázquez Sánchez J. Salgado-Parente A, et al. Among authors: lopez parra md. Radiol Case Rep. 2023 Oct 14;18(12):4522-4527. doi: 10.1016/j.radcr.2023.09.034. eCollection 2023 Dec. Radiol Case Rep. 2023. PMID: 37868005 Free PMC article.
60 results